The current analyst and expert consensus on DelMar Pharmaceuticals is Strong Buy with 0 strong sell and 3 strong buy opinions. The current projected target price consensus is 14.84 with 5 analysts opinions. The most common way DelMar Pharmaceuticals analysists use to provide recommendation to public is financial statements analysis. Many experts also interview DelMar Pharmaceuticals executives and customers to further validate their buy or sell advice. Please note, the number of analysists providing the opinion is not sufficient to provide adequate consensus on DelMar Pharmaceuticals. We encourage you to use your own analysis of DelMar Pharmaceuticals to validate this buy or sell advice. DelMar Pharmaceuticals buy or sell recommendation module provides average expert sentiment on the projected DelMar Pharmaceuticals target price to derive its highest and lowest estimates based on projected price volatility of 3.335. Additionally see Investing Opportunities.